Home/Filings/4/0001310204-25-000005
4//SEC Filing

Dickinson Andrew D 4

Accession 0001310204-25-000005

CIK 0000882095other

Filed

Aug 17, 8:00 PM ET

Accepted

Aug 18, 7:34 PM ET

Size

4.8 KB

Accession

0001310204-25-000005

Insider Transaction Report

Form 4
Period: 2025-08-15
Dickinson Andrew D
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2025-08-15$118.53/sh2,500$296,325160,110 total
Footnotes (1)
  • [F1]The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024.

Issuer

GILEAD SCIENCES, INC.

CIK 0000882095

Entity typeother

Related Parties

1
  • filerCIK 0001310204

Filing Metadata

Form type
4
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 7:34 PM ET
Size
4.8 KB